The polymorphisms within the RPSAP52 gene were associated with schizophrenia in founder populations [34] and associated with biomarkers of Alzheimer’s disease, such as cerebrospinal fluid beta-amyloid 1–42 levels [35]. The gene discussed is RPSAP52; the disease is Alzheimer disease.